Firefly Neuroscience, Inc.
AIFF
$2.66
$0.0110.42%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 2,890.00% | 258.33% | 178.95% | 43.48% | -97.78% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 2,890.00% | 258.33% | 178.95% | 43.48% | -97.78% |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | 2,640.00% | 258.33% | 178.95% | 43.48% | -97.78% |
| SG&A Expenses | 71.06% | 120.64% | 39.88% | 1,131.29% | 61.23% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 52.32% | 91.12% | 64.88% | 541.94% | 65.02% |
| Operating Income | -29.79% | -89.28% | -63.50% | -559.66% | -295.91% |
| Income Before Tax | -44.70% | -1,052.41% | -251.58% | -559.85% | -291.33% |
| Income Tax Expenses | -- | -- | 100.00% | -- | -- |
| Earnings from Continuing Operations | -45.02% | -1,052.41% | -251.44% | -559.85% | -291.33% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -45.02% | -1,052.41% | -251.44% | -559.85% | -291.33% |
| EBIT | -29.79% | -89.28% | -63.50% | -559.66% | -295.91% |
| EBITDA | -29.99% | -- | -63.61% | -562.63% | -299.68% |
| EPS Basic | 40.53% | -706.25% | -48.73% | -242.78% | -2,544.57% |
| Normalized Basic EPS | 40.70% | -501.19% | -13.91% | -242.93% | -2,568.42% |
| EPS Diluted | 40.53% | -706.25% | -48.73% | -242.78% | -2,544.57% |
| Normalized Diluted EPS | 40.70% | -501.19% | -13.91% | -242.93% | -2,568.42% |
| Average Basic Shares Outstanding | 143.88% | 91.67% | 136.27% | 92.47% | -85.27% |
| Average Diluted Shares Outstanding | 143.88% | 91.67% | 136.27% | 92.47% | -85.27% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |